NoxO1 regulates EGFR signaling by its interaction with Erbin

被引:0
作者
Hebchen, Dana Maureen [1 ]
Schader, Tim [1 ]
Spaeth, Manuela [1 ]
Mueller, Niklas [1 ]
Graumann, Johannes [3 ,4 ]
Schroeder, Katrin [1 ,2 ]
机构
[1] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Frankfurt, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Frankfurt, Germany
[3] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany
[4] Philipps Univ Marburg, Inst Translat Prote, Biochem Pharmacol Ctr, Marburg, Germany
来源
REDOX BIOLOGY | 2024年 / 77卷
关键词
NADPH oxidase; EGF signaling; Erbin; NoxO1; NADPH OXIDASES; PROTEIN; BIOTINYLATION; MECHANISMS; PHYSIOLOGY; FAMILY;
D O I
10.1016/j.redox.2024.103396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NADPH oxidase organizer 1 (NoxO1) is a scaffold cytoplasmic subunit of the reactive oxygen species (ROS) forming Nox1 complex and involved in angiogenesis, differentiation, and atherosclerosis. We found that overexpression of NoxO1 without simultaneous overexpression of any other component of the active Nox1 complex inhibited EGF-induced wound closure and signaling, while NoxO1 KO yielded the opposite effect. Accordingly, we hypothesize NoxO1 to exert Nox1 independent functions. Using the BioID technique, we identified ErbB2 interacting protein (Erbin) as novel interaction partner of NoxO1. Colocalization of NoxO1 with EGFR, as well as with Erbin validated this finding. EGF treatment interrupted colocalization of NoxO1 and EGFR. EGF mediated kinase activation was delayed in NoxO1 overexpressing cells, while knockout of NoxO1 had the opposite effect. In conclusion, Erbin was identified as a novel NoxO1 interacting protein. Through the subsequent interaction of NoxO1 and EGFR, NoxO1 interferes with EGF signaling. The results of this study suggest a potential role of NoxO1 as an adaptor protein with functions beyond the well-established enabling of Nox1 mediated ROS formation.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] The paradoxical functions of EGFR during breast cancer progression
    Ali, Remah
    Wendt, Michael K.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2017, 2
  • [2] The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
    Altenhofer, Sebastian
    Kleikers, Pamela W. M.
    Radermacher, Kim A.
    Scheurer, Peter
    Hermans, J. J. Rob
    Schiffers, Paul
    Ho, Heidi
    Wingler, Kirstin
    Schmidt, Harald H. H. W.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (14) : 2327 - 2343
  • [3] ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
    Arteaga, Carlos L.
    Engelman, Jeffrey A.
    [J]. CANCER CELL, 2014, 25 (03) : 282 - 303
  • [4] The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
    Bedard, Karen
    Krause, Karl-Heinz
    [J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (01) : 245 - 313
  • [5] ERBIN:: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor
    Borg, JP
    Marchetto, S
    Le Bivic, A
    Ollendorff, V
    Jaulin-Bastard, F
    Saito, H
    Fournier, E
    Adélaïde, J
    Margolis, B
    Birnbaum, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (07) : 407 - 414
  • [6] EPIDERMAL GROWTH-FACTOR
    CARPENTER, G
    COHEN, S
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 : 193 - 216
  • [7] New targets in triple-negative breast cancer
    Copeland, Robert L.
    Kanaan, Yasmine
    [J]. NATURE REVIEWS CANCER, 2021, 21 (12) : 744 - 744
  • [8] Dang P.M.-C., 2023, NADPH OXIDASES REVISITED: from Function to Structure, P249
  • [9] Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System
    Forrester, Steven J.
    Kawai, Tatsuo
    O'Brien, Shannon
    Thomas, Walter
    Harris, Raymond C.
    Eguchi, Satoru
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 627 - 653
  • [10] EGF receptor inhibitors in the treatment of glioblastoma multiform: Old clinical allies and newly emerging therapeutic concepts
    Gadji, Macoura
    Crous, Ana-Maria Tsanaclis
    Fortin, David
    Krcek, Jerry
    Torchia, Mark
    Mai, Sabine
    Drouin, Regen
    Klonisch, Thomas
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 625 (1-3) : 23 - 30